BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19362980)

  • 1. Transplantation for IgM amyloidosis and IgM myeloma.
    Gertz MA; Hayman SR; Buadi FK
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):77-9. PubMed ID: 19362980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM amyloidosis: clinical features in therapeutic outcomes.
    Gertz MA; Buadi FK; Hayman SR
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):146-8. PubMed ID: 21454218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplantation and IgM amyloidosis.
    Valente M; Roy V; Lacy MQ; Dispenzieri A; Gertz MA
    Leuk Lymphoma; 2006 Jun; 47(6):1006-12. PubMed ID: 16840189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
    Dispenzieri A; Seenithamby K; Lacy MQ; Kumar SK; Buadi FK; Hayman SR; Dingli D; Litzow MR; Gastineau DA; Inwards DJ; Micallef IN; Ansell SM; Johnston PB; Porrata LF; Patnaik MM; Hogan WJ; Gertz MA
    Bone Marrow Transplant; 2013 Oct; 48(10):1302-7. PubMed ID: 23604010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain Amyloidosis.
    Sachchithanantham S; Roussel M; Palladini G; Klersy C; Mahmood S; Venner CP; Gibbs S; Gillmore J; Lachmann H; Hawkins PN; Jaccard A; Merlini G; Wechalekar AD
    J Clin Oncol; 2016 Jun; 34(17):2037-45. PubMed ID: 27114592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation for amyloidosis.
    Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S
    Curr Opin Oncol; 2007 Mar; 19(2):136-41. PubMed ID: 17272986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic factors in light chain amyloidosis].
    Jávorniczky NR; Bodó I; Masszi T; Mikala G
    Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation and treatment responses in IgM-related AL amyloidosis.
    Sissoko M; Sanchorawala V; Seldin D; Sworder B; Angelino K; Broce M; Berk J; Sloan JM
    Amyloid; 2015; 22(4):229-35. PubMed ID: 26488936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
    Nasr SH; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Lacy M; Dispenzieri A; Rajkumar SV; Kyle RA; Leung N
    Am J Kidney Dis; 2012 Jun; 59(6):786-94. PubMed ID: 22417785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?
    Bahlis NJ; Lazarus HM
    Bone Marrow Transplant; 2006 Jul; 38(1):7-15. PubMed ID: 16715110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose therapy in multiple myeloma and primary amyloidosis: an overview.
    Kyle RA
    Semin Oncol; 1999 Feb; 26(1):74-83. PubMed ID: 10073564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis.
    Girnius S; Seldin DC; Skinner M; Finn KT; Quillen K; Doros G; Sanchorawala V
    Ann Hematol; 2010 Jun; 89(6):579-84. PubMed ID: 20012043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloablative chemotherapy and stem cell transplantation in myeloma or primary amyloidosis with renal involvement.
    Gertz MA; Leung N; Lacy MQ; Dispenzieri A
    Kidney Int; 2005 Oct; 68(4):1464-71. PubMed ID: 16164623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation study.
    Bird JM; Fuge R; Sirohi B; Apperley JF; Hunter A; Snowden J; Mahendra P; Milligan D; Byrne J; Littlewood T; Fegan C; McQuaker G; Pagliuca A; Johnson P; Rahemtulla A; Morris C; Marks DI;
    Br J Haematol; 2006 Aug; 134(4):385-90. PubMed ID: 16822294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgM AL amyloidosis due to B cell lymphoproliferative disorder: efficacy of high-dose melphalan followed by autologous stem cell transplantation.
    Gono T; Matsuda M; Shimojima Y; Ishii W; Yamamoto K; Koyama J; Sakashita K; Koike K; Itoh S; Isaka T; Ikeda S
    Amyloid; 2004 Jun; 11(2):130-5. PubMed ID: 15478470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Outcomes of AL-amyloidosis treatment with bortezomib, dexamethasone and cyclophosphamide or doxorubicin-containing regimens].
    Adam Z; Stork M; Pour L; Krejčí M; Zahradová L; Sandecká V; Hájek R; Cermáková Z; Pospíšilová Y; Navrátil M; Král Z; Mayer J
    Vnitr Lek; 2012 Dec; 58(12):896-903. PubMed ID: 23427947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation.
    Raschle J; Banz Y; Suter T; Pabst T
    Swiss Med Wkly; 2014 Feb; 144():w13922. PubMed ID: 24554372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients.
    Terrier B; Jaccard A; Harousseau JL; Delarue R; Tournilhac O; Hunault-Berger M; Hamidou M; Dantal J; Bernard M; Grosbois B; Morel P; Coiteux V; Gisserot O; Rodon P; Hot A; Elie C; Leblond V; Fermand JP; Fakhouri F
    Medicine (Baltimore); 2008 Mar; 87(2):99-109. PubMed ID: 18344807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous stem cell transplantation in light-chain amyloidosis patients: a single-center experience in Korea.
    Kim SJ; Lee GY; Jang HR; Choi JO; Kim JS; Kim HJ; Lee SY; Min JH; Jeon ES; Kim K
    Amyloid; 2013 Dec; 20(4):204-11. PubMed ID: 23914780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation.
    Dimopoulos MA
    Leuk Lymphoma; 2006 Jun; 47(6):963-4. PubMed ID: 16840183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.